Literature DB >> 22503566

Sgp3 and TLR7 stimulation differentially alter the expression profile of modified polytropic retroviruses implicated in murine systemic lupus.

Valérie Leroy1, Masao Kihara, Lucie Baudino, Guy Brighouse, Leonard H Evans, Shozo Izui.   

Abstract

The envelope glycoprotein, gp70, of endogenous retroviruses represents one of the major nephritogenic autoantigens implicated in murine systemic lupus erythematosus. Among different endogenous retroviruses (ecotropic, xenotropic and polytropic), lupus-prone mice express remarkably high levels of modified polytropic (mPT) retroviruses, which are controlled by the Sgp3 (serum gp70 production) locus. To define the contribution of the Sgp3 locus derived from lupus-prone mice to the expression of the specific mPT proviruses, the genetic origin of different mPT viruses expressed in livers and thymi of wild-type and Sgp3 congenic C57BL/6 mice was determined through clonal analysis of their transcripts. Among 13 mPT proviruses present in the C57BL/6 genome, only 3 proviruses (Mpmv6, Mpmv10 and Mpmv13) were selectively but differentially expressed in livers and thymi. This was likely a result of co-regulated expression with host genes because of their integration in the same transcriptional direction. In contrast, Sgp3 induced the steady-state expression of an additional select group of mPT proviruses and, after stimulation of TLR7, the highly upregulated expression of a potentially replication-competent mPT virus Mpmv4. These results indicated that the expression of distinct subpopulations of mPT retroviruses was regulated by Sgp3- and TLR7-dependent mechanisms. The induction of potentially replication-competent mPT viruses and the upregulation of one such virus after stimulation with TLR7 in Sgp3 congenic mice further highlight the implication of Sgp3 in autoimmune responses against nephritogenic serum gp70 through the activation of TLR7.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503566      PMCID: PMC3358543          DOI: 10.1016/j.jaut.2012.03.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  46 in total

1.  Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone PXSB mice.

Authors:  M E Haywood; T J Vyse; A McDermott; E M Thompson; A Ida; M J Walport; S Izui; B J Morley
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

2.  Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.

Authors:  Christopher J Krebs; Leslie K Larkins; Ryan Price; Kathryn M Tullis; Raymond D Miller; Diane M Robins
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

3.  The Sgp3 locus on mouse chromosome 13 regulates nephritogenic gp70 autoantigen expression and predisposes to autoimmunity.

Authors:  Catherine Laporte; Benoît Ballester; Charles Mary; Shozo Izui; Luc Reininger
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

4.  Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus.

Authors:  B P Croker; B C del Villano; F C Jensen; R A Lerner; F J Dixon
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

5.  Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.

Authors:  Marie-Laure Santiago-Raber; Hirofumi Amano; Eri Amano; Lucie Baudino; Masako Otani; Qingshun Lin; Falk Nimmerjahn; J Sjef Verbeek; Jeffrey V Ravetch; Yoshinari Takasaki; Sachiko Hirose; Shozo Izui
Journal:  Arthritis Rheum       Date:  2009-08

6.  Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70.

Authors:  R A Lerner; C B Wilson; B C Villano; P J McConahey; F J Dixon
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

7.  Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus.

Authors:  J S Tung; E S Vitetta; E Fleissner; E A Boyse
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

8.  The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes.

Authors:  B C Del Vellano; B Nave; B P Croker; R A Lerner; F J Dixon
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

9.  Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Authors:  Marie-Laure Santiago-Raber; Roberto Baccala; Katarina M Haraldsson; Divaker Choubey; Timothy A Stewart; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

10.  The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.

Authors:  T Yoshiki; R C Mellors; M Strand; J T August
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  3 in total

1.  Endogenous retroviruses mobilized during friend murine leukemia virus infection.

Authors:  Stefano Boi; Kyle Rosenke; Ethan Hansen; Duncan Hendrick; Frank Malik; Leonard H Evans
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

2.  Three Sgp loci act independently as well as synergistically to elevate the expression of specific endogenous retroviruses implicated in murine lupus.

Authors:  Kiyoaki Ito; Lucie Baudino; Masao Kihara; Valérie Leroy; Timothy J Vyse; Leonard H Evans; Shozo Izui
Journal:  J Autoimmun       Date:  2013-03-07       Impact factor: 7.094

3.  Identification of a lupus-susceptibility locus leading to impaired clearance of apoptotic debris on New Zealand Black chromosome 13.

Authors:  E Pau; C Loh; G E S Minty; N-H Chang; J E Wither
Journal:  Genes Immun       Date:  2013-01-17       Impact factor: 2.676

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.